Results 261 to 270 of about 217,331 (294)

Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Chronic kidney disease (CKD) is a serious complication occurring in nearly one of three people with type 1 diabetes (T1D). Major therapeutic advances have been made in the management of CKD for people with type 2 diabetes (T2D), thereby improving their kidney, cardiovascular, and survival outcomes.
Katherine R. Tuttle, Linong Ji, Chantal Mathieu, Jonathan Rosen   +3 more
wiley   +1 more source

A rare case of dual glomerular pathology: Alport syndrome and immune complex-mediated MPGN. [PDF]

BMC Nephrol
Ozcan SG, Koc E, Murt A, Dincer MT, Gurses I, Seyahi N, Trabulus S.   +6 more
europepmc   +1 more source

Detection of haematuria and proteinuria reflects injury to significantly different glomerular surface areas: a quantitative hypothesis. [PDF]

Clin Kidney J
Uemura O.
europepmc   +1 more source

Efficacy and safety of European Medicines Agency (EMA)‐approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta‐analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We aimed at comparing different approved strategies (obesity management medications—OMM, endoscopic bariatric procedures—EBP, and metabolic bariatric surgery—MBS) with lifestyle intervention/placebo/no therapy (LSI/Pbo/NT) for the treatment of different BMI‐based classes of obesity (i.e., overweight—BMI: 25–29.9 kg/m2; class I—BMI: 30–34 ...
Rocco Barazzoni, Matteo Monami, Silvio Buscemi, Luca Busetto, Maurizio De Luca, Giuseppe Navarra, Benedetta Ragghianti, Giovanni Antonio Silverii, Amanda Belluzzi, Edoardo Mannucci, Paolo Sbraccia   +10 more
wiley   +1 more source

Comment on: NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis: Reply. [PDF]

Rheumatology (Oxford)
Guliyeva V, Demirkan FG, Bektaş E, Deniz R, Emrence Z, Akgün Ö, Arık SD, Doğru A, Tanatar A, Abacı N, Ekmekci SS, Gül A, Aktay Ayaz N.   +12 more
europepmc   +1 more source

FK 506 in the management of nephrotic syndrome after renal transplantation [PDF]

, 1993
Jensen, C, Jordan, M, McCauley, J, Scantlebury, V, Shapiro, R, Starzl, TE, Vivas, C   +6 more
core  

Current management of non‐amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes

British Journal of Haematology, EarlyView.
Daniel Cancilla, Hanny Sawaf, Xuefei Jia, Danai Dima, Ali Mehdi, Hira Shaikh, Beth Faiman, Faiz Anwer, Sandra Mazzoni, Diana Basali, Jack Khouri, Christy Samaras, Jason Valent, Shahzad Raza, Louis Williams   +14 more
wiley   +1 more source

Comparison of the renal outcomes of novel antidiabetic agents in patients with type 2 diabetes with chronic kidney disease: A systematic review and network meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To investigate the renal outcomes of dipeptidyl peptidase 4 (DPP‐4) inhibitors, glucagon‐like peptide‐1 (GLP‐1) receptor agonists, and sodium‐glucose transport protein‐2 (SGLT‐2) inhibitors in patients with type 2 diabetes mellitus (T2DM) with chronic renal disease (CKD).
Rong Lin, Chia‐Li Hsu, Ming‐Chieh Shih, Kuo‐Liong Chien, Hon‐Yen Wu   +4 more
wiley   +1 more source

Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review. [PDF]

J Clin Med
Koirala A, Singh A, Geetha D.
europepmc   +1 more source

Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Managing blood pressure (BP) in older adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) remains controversial, particularly regarding optimal targets and the impact of inadequate monitoring. Using Clinical Practice Research Datalink (CPRD) data, this study assessed associations between baseline systolic and diastolic BP ...
Anna Meffen, Freya Tyrer, Junior Mbah Mbahnjeck, Kamlesh Khunti, Francesco Zaccardi, Setor K. Kunutsor   +5 more
wiley   +1 more source